RankingsPricing
  1. US-listed companies
  2. EXELIXIS, INC.
  3. Financials
  4. Research & development

EXELIXIS, INC.EXEL

Market cap
$11.6B
P/E ratio
SummaryFinancials
Period EndResearch & development (Million USD)YoY (%)
Jan 3, 2025910-12.80%
Dec 29, 20231,044+17.07%
Dec 30, 2022892+28.56%
Dec 31, 2021694+26.62%
Jan 1, 2021548+62.58%
Jan 3, 2020337+84.88%
Dec 28, 2018182+62.48%
Dec 29, 2017112-12.96%
Dec 31, 2012129-17.83%
Dec 31, 2011157

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)